🔗 Share this article

Grammy-winning R&B singer D’Angelo died on the fourteenth of October at 51 years old after a private battle with pancreatic malignancy.

“The shining star of our household has faded away for us in the present world,” his family confirmed. “After a lengthy and brave struggle with cancer, we are deeply saddened to declare that D’Angelo, recognized by his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on the music industry with his pioneering modern soul style and collaborations with renowned musicians.

He launched his first record, “Brown Sugar,” in the mid-nineties to immediate acclaim. The album achieved the fourth spot on the R&B charts, earned platinum status soon after, and earned several Grammy nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his artistic journey into the stratosphere. The album debuted at No. 1 on each of Billboard’s Top R&B Albums chart and the main album chart. He won two Grammys: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a reluctant one, in the cultural zeitgeist. The intimate portrayal showed the artist, famously bare to his waist, performing directly into the lens.

D’Angelo retreated from the public eye after putting out Voodoo and publicly struggled with substance abuse. In 2005, he was part of a severe vehicle accident that left him in grave health.

More than a decade later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with another top chart entry on the soul music rankings and a award for Best R&B Album.

Once more, in his own enigmatic fashion, D’Angelo had limited public appearances in the following years.

The singer was announced as a top act for the 2025 music event, but his appearance was called off, due to an “unforeseen medical delay.”

Even though information is limited about D’Angelo’s health in the weeks leading up to his death, he had reportedly been hospitalized for months and in hospice for two weeks.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic cancer, one of the deadliest and least preventable forms of the disease, on a brilliant talent whose existence was cut short.

“We are grieved that he can only leave dear memories with his family, but we are eternally grateful for the heritage of extraordinarily moving songs he has left us,” his family expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic cancer affects the pancreas, a small organ that produces insulin and is vital in breaking down food, among other functions. The size and location of the organ in the human system make it more challenging to detect malignancy.

Even though this cancer makes up only approximately three percent of malignancy cases each year in the United States, it is responsible for 7% of malignancy fatalities.

Nearly 70,000 people will be diagnosed with pancreatic cancer and roughly 52,000 will die of the disease in the year 2025.

“This malignancy is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have limited and ineffective treatment options, and a smaller window to make a meaningful impact on the well-being of patients,” said a cancer specialist.

Since this disease rarely causes initial signs, it’s often identified only after the disease is advanced. Even when a patient has symptoms they are often vague and may be confused with a several common illnesses.

“As of yet, there is no good way to identify pancreatic cancer in the initial phases, except for listening to your body and consulting your physician if there are unfamiliar symptoms,” said a medical director.

Frequent indicators of pancreatic cancer encompass:

• abdominal or lower back pain
• weight loss
• jaundice
• reduced hunger
• dark urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• nausea

At 51 years old, D’Angelo’s death is an exception, as this malignancy is most common in adults in the 65 to 75 age bracket. However, many cancers, including pancreatic cancer, have become increasingly prevalent in younger adults.

“Pancreatic cancer identified before the age of 50 is deemed uncommon, yet concerningly, clinicians are noticing a growing number of younger individuals suffering from this condition,” said a expert.

Family History Affects Disease Probability

Without reliable detection methods for pancreatic cancer, experts stressed the significance of understanding your relatives’ cancer history. Certain risk factors, such as smoking and excess weight also play a role in the onset of pancreatic cancer.

Black individuals have the greatest occurrence of pancreatic cancer in the United States and are most likely to be diagnosed with untreatable disease.

“The first step toward reducing one’s chance of pancreatic cancer is understanding personal risk factors. People should examine their genetic background, hereditary factors, and medical conditions, such as blood sugar disease, long-term pancreas inflammation, or obesity that may raise their susceptibility,” advised a specialist.

Hereditary elements are linked to as much as 10% of all this malignancy cases. If someone in your family has had pancreatic cancer, you may want to consider DNA analysis.

“For people with a relative’s background of pancreatic cancer or those carrying high risk DNA changes, checking may involve sophisticated scans such as magnetic resonance imaging (MRI) or internal ultrasound to find early changes in the pancreas,” he clarified.

For those wishing to lower their chance, habit adjustments may have an effect. The most effective step you can take to reduce your susceptibility of this disease is to quit smoking, and if you are a non-smoker, avoid exposure altogether.

Excessive drinking is associated with pancreatitis, a risk factor for this malignancy, so limiting or avoiding drinks may help reduce your risk.

Controlling your body mass or losing weight may also help reduce your risk. Individuals with obesity are 20% more likely to get this disease. This malignancy also is more frequent in those with blood sugar issues, and reducing weight can also lower the risk of type 2 diabetes.

In spite of this disease’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and newer combination chemotherapy. There are emerging precision medicines that are already making an impact,” said a expert.

For many people, however, education about this uncommon but {dev